TB stigma still keeps people from testing and treatment in SA
As the world marks World TB Day, fear of judgment and poor support remain major barriers to TB care in South Africa.
Health
Read More » TB stigma still keeps people from testing and treatment in SA
Labelling diabetes a lifestyle disease reinforces stigma
Patients need encouragement and positive language to make the change needed to improve their quality of life while they manage the chronic condition.
Lenacapavir: There are mounting concerns over transparency in costÂ
South Africa may be able to start rolling out lenacapavir (LEN), the twice-yearly HIV prevention jab, in January 2026 – three months earlier than initially planned. But the details of the agreement that will bring the drug into the country…
Calls for South Africa to build sustainable HIV programmes, reduce reliance on donorsÂ
Instead of looking backwards and how to find more money, we should be looking forward and changing the way we run the programme and the entire primary healthcare system.
Activists warn: All gains in HIV fight at risk without urgent action
HIV testing had decreased by 8.5% from the first quarter of 2024 to the first quarter of 2025.
Lenacapavir could be added to HIV prevention toolkit by 2026
Studies done in various countries, including South Africa, have shown that lenacapavir is highly effective for HIV prevention.
South Africa continues to grapple with TB deaths
South Africa is recording higher TB deaths among HIV-negative people.
U.S Senate vote protects PEPFAR funds
This week, the U.S. Senate made a move that’s given the HIV community some hope: they voted to protect PEPFAR from $400 million cuts proposed in Donald Trump’s rescission package.Â
WHO endorses lenacapavir to end AIDS by 2030
Lenacapavir will help expand coverage for those who are not accessing oral PrEP.
UNAIDS warns global HIV gains at risk as donor funding plummets
The lifelong and chronic illness caused by untreated HIV has a knock-on effect on development.
Pushback against foreign nationals using public health facilitiesÂ
Dudula members have also accused foreign nationals of collecting medication to manufacture nyaope, a street drug.
Patients Left in Limbo as MRI Services Collapse Under Pressure in Gauteng
The growing waiting lists raise serious concerns about delays in diagnosis and treatment, particularly for time-sensitive conditions such as cancer and neurological disorders.
U.S approves twice-yearly HIV prevention drug, but it’s unaffordable for countries most in need
Researchers at the University of Liverpool have indicated that this HIV prevention drug could be manufactured and rolled out at around $40 per person per year.
mRNA technology transfer programme reaches key milestone
mRNA foundational technology has successfully been transferred to 15 partner organisations.
SAHPRA warns of fake licences and hidden health dangers in cannabis-infused products
Symptoms of consuming cannabis-infused drinks or snacks can include hallucinations, euphoria, paranoia, confusion, increased heart rate, and dry mouth.